130 related articles for article (PubMed ID: 8279553)
21. Effect of NSAIDs on pepsinogen secretion and calcium mobilization in isolated chief cells.
Fiorucci S; Santucci L; Gresele P; Luinetti O; Morelli A
Am J Physiol; 1995 Jun; 268(6 Pt 1):G968-78. PubMed ID: 7611418
[TBL] [Abstract][Full Text] [Related]
22. Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid.
Raulf M; König W
Immunology; 1988 May; 64(1):51-9. PubMed ID: 2838420
[TBL] [Abstract][Full Text] [Related]
23. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
[TBL] [Abstract][Full Text] [Related]
24. Murine glomerular leukotriene B4 synthesis. Manipulation by (n-6) fatty acid deprivation and cellular origin.
Lefkowith JB; Morrison AR; Schreiner GF
J Clin Invest; 1988 Nov; 82(5):1655-60. PubMed ID: 2846657
[TBL] [Abstract][Full Text] [Related]
25. Effects of n-3 polyunsaturated fatty acids on indomethacin-induced changes in eicosanoid production and blood flow in the gastric mucosa of rats.
Shimizu T; Suzuki M; Lee T; Igarashi J; Kaneko K; Yamashiro Y
Prostaglandins Leukot Essent Fatty Acids; 2003 Jul; 69(1):33-7. PubMed ID: 12878448
[TBL] [Abstract][Full Text] [Related]
26. The Chinese herbal medicine, shinpi-to, inhibits IgE-mediated leukotriene synthesis in rat basophilic leukemia-2H3 cells.
Hamasaki Y; Kobayashi I; Hayasaki R; Zaitu M; Muro E; Yamamoto S; Ichimaru T; Miyazaki S
J Ethnopharmacol; 1997 Apr; 56(2):123-31. PubMed ID: 9174973
[TBL] [Abstract][Full Text] [Related]
27. Leukotriene metabolism by intrapulmonary vessels of newborn lambs: effect of platelet-activating factor.
Ibe BO; Raj JU
Exp Lung Res; 2001 Jun; 27(4):331-48. PubMed ID: 11400860
[TBL] [Abstract][Full Text] [Related]
28. The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2.
Tries S; Neupert W; Laufer S
Inflamm Res; 2002 Mar; 51(3):135-43. PubMed ID: 12005204
[TBL] [Abstract][Full Text] [Related]
29. Leukotriene production by cultured astroglial cells.
Hartung HP; Toyka KV
Brain Res; 1987 Dec; 435(1-2):367-70. PubMed ID: 3123012
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of leukotriene synthesis by azelastine.
Hamasaki Y; Shafigeh M; Yamamoto S; Sato R; Zaitu M; Muro E; Kobayashi I; Ichimaru T; Tasaki H; Miyazaki S
Ann Allergy Asthma Immunol; 1996 May; 76(5):469-75. PubMed ID: 8630722
[TBL] [Abstract][Full Text] [Related]
31. Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
[TBL] [Abstract][Full Text] [Related]
32. Release of leukotriene B4 from rat Kupffer cells.
Sakagami Y; Mizoguchi Y; Seki S; Kobayashi K; Morisawa S; Yamamoto S
Prostaglandins Leukot Essent Fatty Acids; 1989 Jun; 36(3):125-8. PubMed ID: 2550963
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of theophylline, terbutaline, and hydrocortisone on leukotriene B4 and C4 generation by human leukocytes in vitro.
Shimizu T; Kristjánsson S; Wennergren G; Hansson GC; Strandvik B
Pediatr Pulmonol; 1994 Sep; 18(3):129-34. PubMed ID: 7800427
[TBL] [Abstract][Full Text] [Related]
34. Leukotrienes C4 and D4 potentiate acid production by isolated rat parietal cells.
Schepp W; Kath D; Tatge C; Zimmerhackl B; Schusdziarra V; Classen M
Gastroenterology; 1989 Dec; 97(6):1420-9. PubMed ID: 2555244
[TBL] [Abstract][Full Text] [Related]
35. In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis.
Fruchtmann R; Mohrs KH; Hatzelmann A; Raddatz S; Fugmann B; Junge B; Horstmann H; Müller-Peddinghaus R
Agents Actions; 1993 Mar; 38(3-4):188-95. PubMed ID: 8213345
[TBL] [Abstract][Full Text] [Related]
36. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
37. Evidence for a dual pathway in platelet activating factor-induced aggregation of rat polymorphonuclear leucocytes.
Moodley I; Stuttle A
Prostaglandins; 1987 Feb; 33(2):253-64. PubMed ID: 3035617
[TBL] [Abstract][Full Text] [Related]
38. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
39. Strain-dependency of leukotriene C4 generation from isolated lungs of immunized mice.
Zuany-Amorim C; Vargaftig BB; Maclouf J; Pretolani M
Br J Pharmacol; 1994 Aug; 112(4):1230-6. PubMed ID: 7524994
[TBL] [Abstract][Full Text] [Related]
40. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
